All Stories

  1. Renoprotection by 5-Methoxytryptophan in Kidney Disease
  2. Rodent Models of D-Galactose Induction of Accelerated Aging: A Platform for Exploring Kidney Aging Mechanisms and Anti-Kidney Aging Strategies
  3. Renoprotection by 5-Methoxytryptophan in Kidney Disease
  4. The Role of Sirt3 in Kidney Health and Disease
  5. Beneficial Effects of Butyrate on Kidney Disease
  6. Mitigating Oxidative Stress and Inflammation: The Protective Role of β-lapachone in Kidney Disease
  7. Diabetic Kidney Disease: Contribution of Phenyl Sulfate Derived from Dietary Tyrosine upon Gut Microbiota Catabolism
  8. Rodent Models of Streptozotocin-Induced Diabetes as Suitable Paradigms for Studying Diabetic Kidney Disease
  9. Redox Imbalance and Mitochondrial Abnormalities in Kidney Disease—Volume II
  10. Orientin Protects BV-2 Microglial Cells against Hypoxia Reoxygenation Injury through Inhibiting Oxidative Stress
  11. Editorial: Diabetes and obesity effects on lung function, volume II
  12. Roles of Dihydrolipoamide Dehydrogenase in Health and Disease
  13. Renal-Protective Roles of Lipoic Acid in Kidney Disease
  14. Long-term intermittent fasting improves neurological function by promoting angiogenesis after cerebral ischemia via growth differentiation factor 11 signaling activation
  15. The Role of Ketone Bodies in Various Animal Models of Kidney Disease
  16. The Nicotinamide/Streptozotocin Rodent Model of Type 2 Diabetes: Renal Pathophysiology and Redox Imbalance Features
  17. Cisplatin-Induced Kidney Toxicity: Potential Roles of Major NAD+-Dependent Enzymes and Plant-Derived Natural Products
  18. Redox Imbalance and Mitochondrial Abnormalities in Kidney Disease
  19. Folic acid‐induced animal model of kidney disease
  20. Activation of peripheral group III metabotropic glutamate receptors suppressed formalin‐induced nociception
  21. Cadmium-Induced Kidney Injury: Oxidative Damage as a Unifying Mechanism
  22. Comment on Kobroob et al. Effectiveness of N-Acetylcysteine in the Treatment of Renal Deterioration Caused by Long-Term Exposure to Bisphenol A. Biomolecules 2021, 11, 655
  23. NADH/NAD+ Redox Imbalance and Diabetic Kidney Disease
  24. <p>Antioxidative and Hypoglycemic Effect of Ta-ermi Extracts on Streptozotocin-Induced Diabetes</p>
  25. Reductive Stress-Induced Mitochondrial Dysfunction and Cardiomyopathy
  26. Urine Sample-Derived Cerebral Organoids Suitable for Studying Neurodevelopment and Pharmacological Responses
  27. Regulation of the SIRT1 signaling pathway in NMDA-induced Excitotoxicity
  28. Neuroprotection of Cyperus esculentus L. orientin against cerebral ischemia/reperfusion induced brain injury
  29. Effects of mesencephalic astrocyte-derived neurotrophic factor on cerebral angiogenesis in a rat model of cerebral ischemia
  30. Effects of dietary 5-methoxyindole-2-carboxylic acid on brain functional recovery after ischemic stroke
  31. Vagus nerve stimulation as a promising adjunctive treatment for ischemic stroke
  32. Role of Catalase in Oxidative Stress- and Age-Associated Degenerative Diseases
  33. Circulating factors in young blood as potential therapeutic agents for age-related neurodegenerative and neurovascular diseases
  34. Role of pseudohypoxia in the pathogenesis of type 2 diabetes
  35. The negative and detrimental effects of high fructose on the liver, with special reference to metabolic disorders
  36. Chronic Inhibition of Mitochondrial Dihydrolipoamide Dehydrogenase (DLDH) as an Approach to Managing Diabetic Oxidative Stress
  37. Humanin Attenuates NMDA-Induced Excitotoxicity by Inhibiting ROS-dependent JNK/p38 MAPK Pathway
  38. Reexploring 5-methoxyindole-2-carboxylic acid (MICA) as a potential antidiabetic agent
  39. Mitochondrial protein sulfenation during aging in the rat brain
  40. Redox imbalance stress in diabetes mellitus: Role of the polyol pathway
  41. Post-ischemic administration of 5-methoxyindole-2-carboxylic acid at the onset of reperfusion affords neuroprotection against stroke injury by preserving mitochondrial function and attenuating oxidative stress
  42. Role and Possible Mechanisms of Sirt1 in Depression
  43. Administration of 5-methoxyindole-2-carboxylic acid that potentially targets mitochondrial dihydrolipoamide dehydrogenase confers cerebral preconditioning against ischemic stroke injury
  44. Ceruloplasmin, a Potential Therapeutic Agent for Alzheimer's Disease
  45. Pancreatic mitochondrial complex I exhibits aberrant hyperactivity in diabetes
  46. Redox imbalance and mitochondrial abnormalities in the diabetic lung
  47. Non‐Gradient Blue Native Polyacrylamide Gel Electrophoresis
  48. The Neuroprotective Effects of SIRT1 on NMDA-Induced Excitotoxicity
  49. Potential Biochemical Mechanisms of Lung Injury in Diabetes
  50. Glutaredoxins concomitant with optimal ROS activate AMPK through S-glutathionylation to improve glucose metabolism in type 2 diabetes
  51. Sources and implications of NADH/NAD+ redox imbalance in diabetes and its complications
  52. Two-dimensional gel electrophoretic detection of protein carbonyls derivatized with biotin-hydrazide
  53. Comparison of antioxidant and antiproliferative activity between Kunlun Chrysanthemum flowers polysaccharides (KCCP) and fraction PII separated by column chromatography
  54. Chemical Conditioning as an Approach to Ischemic Stroke Tolerance: Mitochondria as the Target
  55. Protein Modifications as Manifestations of Hyperglycemic Glucotoxicity in Diabetes and Its Complications
  56. Hyperglycemic Stress and Carbon Stress in Diabetic Glucotoxicity
  57. Cerebral small vessel disease and Alzheimer’s disease
  58. Role of RAGE in Alzheimer’s Disease
  59. Streptozotocin-induced type 1 diabetes in rodents as a model for studying mitochondrial mechanisms of diabetic β cell glucotoxicity
  60. Activation of mTOR: a culprit of Alzheimer’s disease?
  61. Two dimensional blue native/SDS-PAGE to identify mitochondrial complex I subunits modified by 4-hydroxynonenal (HNE)
  62. Antioxidant Activity, Antitumor Effect, and Antiaging Property of Proanthocyanidins Extracted fromKunlun ChrysanthemumFlowers
  63. Roles of Pyruvate, NADH, and Mitochondrial Complex I in Redox Balance and Imbalance inβCell Function and Dysfunction
  64. Mitochondrial Dihydrolipoamide Dehydrogenase Is Upregulated in Response to Intermittent Hypoxic Preconditioning
  65. Role of insulin resistance in Alzheimer’s disease
  66. PTEN degradation after ischemic stroke: A double-edged sword
  67. Cancer-associated Isocitrate Dehydrogenase 1 (IDH1) R132H Mutation and D-2-Hydroxyglutarate Stimulate Glutamine Metabolism under Hypoxia
  68. Protein Redox Modification as a Cellular Defense Mechanism against Tissue Ischemic Injury
  69. Positive oxidative stress in aging and aging-related disease tolerance
  70. Pathogenesis of Chronic Hyperglycemia: From Reductive Stress to Oxidative Stress
  71. Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer's disease
  72. Reversible inactivation of dihydrolipoamide dehydrogenase by mitochondrial hydrogen peroxide
  73. Telomere Shortening and Alzheimer’s Disease
  74. Neuroprotective Actions of Methylene Blue and Its Derivatives
  75. Roles of AMP-activated Protein Kinase in Alzheimer’s Disease
  76. Ethanol withdrawal acts as an age-specific stressor to activate cerebellar P38 kinase
  77. Chemical probes for analysis of carbonylated proteins: A review
  78. Alternative Mitochondrial Electron Transfer as a Novel Strategy for Neuroprotection
  79. Nongradient blue native gel analysis of serum proteins and in-gel detection of serum esterase activities
  80. Resolving mitochondrial protein complexes using nongradient blue native polyacrylamide gel electrophoresis
  81. Analysis of Oxidative Modification of Proteins
  82. Estrogen Receptor   as a Mitochondrial Vulnerability Factor
  83. Analysis of Oxidative Modification of Proteins
  84. Changes in dihydrolipoamide dehydrogenase expression and activity during postnatal development and aging in the rat brain
  85. Ethanol withdrawal provokes mitochondrial injury in an estrogen preventable manner
  86. Human αB-Crystallin Mutation Causes Oxido-Reductive Stress and Protein Aggregation Cardiomyopathy in Mice
  87. Histochemical staining and quantification of dihydrolipoamide dehydrogenase diaphorase activity using blue native PAGE
  88. Hypoxia-inducible Factor 2  Regulates Expression of the Mitochondrial Aconitase Chaperone Protein Frataxin
  89. Pyruvate protects mitochondria from oxidative stress in human neuroblastoma SK-N-SH cells
  90. Mass spectrometry-based survey of age-associated protein carbonylation in rat brain mitochondria
  91. Mouse HSF1 Disruption Perturbs Redox State and Increases Mitochondrial Oxidative Stress in Kidney
  92. Multiple organ pathology, metabolic abnormalities and impaired homeostasis of reactive oxygen species in Epas1−/− mice
  93. Mouse heat shock transcription factor 1 deficiency alters cardiac redox homeostasis and increases mitochondrial oxidative damage
  94. Analysis of Oxidative Modification of Proteins
  95. Heat shock factor 1 and heat shock proteins: Critical partners in protection against acute cell injury
  96. Prevention of flight activity prolongs the life span of the housefly, Musca domestica, and attenuates the age-associated oxidative damamge to specific mitochondrial proteins
  97. Effects of aging and hyperoxia on oxidative damage to cytochrome c in the housefly, Musca domestica1
  98. Analysis of Oxidative Modification of Proteins
  99. Gel Electrophoretic Quantitation of Protein Carbonyls Derivatized with Tritiated Sodium Borohydride
  100. Mitochondrial adenine nucleotide translocase is modified oxidatively during aging
  101. Identification of Oxidized Proteins Based on Sodium Dodecyl Sulfate–Polyacrylamide Gel Electrophoresis, Immunochemical Detection, Isoelectric Focusing, and Microsequencing
  102. Macromolecular carbonyls in human stratum corneum: a biomarker for environmental oxidant exposure?
  103. UV-Irradiation Depletes Antioxidants and Causes Oxidative Damage in a Model of Human Skin
  104. The Lipoic Acid Analogue 1,2-Diselenolane-3-pentanoic Acid Protects Human Low Density Lipoprotein against Oxidative Modification Mediated by Copper Ion
  105. Oxidative damage during aging targets mitochondrial aconitase
  106. Apolipoprotein B Carbonyl Formation Is Enhanced by Lipid Peroxidation during Copper-Mediated Oxidation of Human Low-Density Lipoproteins
  107. Efficacy of Hypochlorous Acid Scavengers in the Prevention of Protein Carbonyl Formation
  108. Antioxidant Activity of Diethyldithiocarbamate
  109. Spectrophotometric Method for Determination of Carbonyls in Oxidatively Modified Apolipoprotein B of Human Low-Density Lipoproteins
  110. Ginkgo Biloba Extract (EGb 761) Protects Human Low-Density Lipoproteins against Oxidative Modification Mediated by Copper
  111. Oxidative DNA damage and senescence of human diploid fibroblast cells.
  112. Elucidation of Antioxidant Activity of α-Lipoic Acid Toward Hydroxyl Radical
  113. Induction of Protein Oxidation in Human Low Lipoprotein by the Photosensitive Organic Hydroperoxide, N,N′-bis(2-Hydroxyperoxy-2-Methoxyethyl)-1,4,5,8-Naphthalene-Tetra-Carboxylic-Diimide
  114. Effects of oxygen radicals on the conformation of sulfhydryl groups on human polymorphonuclear leukocyte membranes
  115. Experimental studies on some aspects of toxicological effects of gas phase cigarette smoke (GPCS)